Wednesday, December 04, 2024

Events | 2009.11.16

Gentium Announces Presentation of Defibrotide Clinical Data at the American Society of Hematology Annual Meeting

VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Gentium S.p.A. (Nasdaq: GENT) announced today that results from the Company’s Phase II/III Pediatric Prevention trial and Phase III Treatment trial for Defibrotide of Hepatic Veno-Occlusive Disease will be presented at American Society of Hematology Conference (ASH), December 5-8 in New Orleans. The results of these trials will be highlighted in two separate oral presentations on Monday, December 7, 2009 during the session, “Clinical Care

 

For more information, please visit
http://www.businesswire.com/news/home/20091116005462/en

You need to login to post comments.

Feed last updated 1969/12/31 @7:00 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News